Insight

Nov 21, 2024, 16:56

Overview and clarification of the current HR+ HER2- EBC treatment landscape – SPCC

SPCC (Sharing Progress in Cancer Care) shared a post on LinkedIn:

“Save the date for our upcoming live session: ‘Overview and clarification of the current HR+ HER2- EBC treatment landscape’.

Topics:

De-escalation and Escalation of Surgery, Radiotherapy, and Adjuvant Treatment of Breast Cancer.
Enhancing and Personalising Adjuvant Endocrine Therapy – Current perspectives and future directions.

Wednesday, 27 November – 18:00 CET
Register here.

This webinar is supported by an unrestricted educational grant from Eli Lilly.”

For more information about the event, visit oncodaily.com.

Breast Cancer cancer EBC treatment Fiorita Poulakaki Michael Gnant OncoDaily Oncology radiotherapy Sharing Progress in Cancer Care SPCC Stephen Johnston

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage